Prope tolerance after pediatric liver transplantation

Pediatric Transplantation

Volumn 17, Issue 1, 2013, Pages 59-64

  Bourdeaux, Christophe ^a   Pire, Aurore ^a   Janssen, Magda ^a   Stéphenne, Xavier ^a   Smets, Francoise ^a   Sokal, Etienne ^a   De Magnée, Catherine ^a   Fusaro, Fabio ^a   Reding, Raymond ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

immunosuppression; liver transplantation; outcome; pediatric; tolerance

Indexed keywords

BASILIXIMAB; DACLIZUMAB; TACROLIMUS;

ACUTE GRAFT REJECTION; ARTICLE; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG TOLERABILITY; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEPATITIS; HUMAN; HYPERTENSION; IMMUNOPROPHYLAXIS; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; LIVING DONOR; SIDE EFFECT;

ADOLESCENT; AGE FACTORS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CHILD; CHILD, PRESCHOOL; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; RECOMBINANT FUSION PROTEINS; STEROIDS; TACROLIMUS; TREATMENT OUTCOME;

EID: 84872770665     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12024     Document Type: Article

References (14)

1. Calne R, Friend P, Moffatt S, et al. Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998: 351: 1701-1702.
2. Calne R,. "Almost tolerance" in the clinic. Transplant Proc 1998: 30: 3846-3848.
3. Reding R, Bourdeaux C, Gras J, et al. The pediatric liver transplantation program at the Université Catholique de Louvain. Acta Gastroenterol Belg 2004: 67: 176-178.
4. Gras J, Gerkens S, Beguin C, et al. Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: Clinical and pharmacoeconomic study in 50 children. Liver Transpl 2008: 14: 469-477.
5. Reding R, Gras J, Sokal E, Otte JB, Davies HFS,. Steroid-free liver transplantation in children. Lancet 2003: 362: 2068-2070.
6. Truong D, Bourdeaux C, Wieërs G, Saussoy P, Latinne D, Reding R,. The immunological monitoring of kidney and liver transplants in adult and pediatric recipients. Transpl Immunol 2009: 22: 18-27.
7. Kelly D, Jara P, Rodeck B, et al. Tacrolimus and steroids versus cyclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: Randomised European multicentre trial. Lancet 2004: 364: 1054-1061.
8. Kelly DA, Lloyd C, Jara P,. Long term follow-up of children receiving tacrolimus or cyclosporine A-ME post liver transplantation. Pediatr Transplant 2007: 11: 110.
9. Shemesh E, Shneider B, Savitzky J, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics 2004: 113: 825-832.
10. Finkenstedt A, Graziadei I, Oberaigner W, et al. Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients. Am J Transplant 2009: 9: 2355-2361.
11. Martínez-Llordella M, Puig-Pey I, Orlando G, et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007: 7: 309-319.
12. Wang C, Sun J, Sheil AG, Mccaughan GW, Bishop GA,. A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allograft. Transplantation 2001: 72: 44-51.
13. Demirkiran A, Hendrikx TK, Baan CC, Van Der Laan LJ,. Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: Does in vitro evidence translate to the clinical setting? Transplantation 2008: 85: 783-789.
14. Bourdeaux C, Darwish A, Jamart J, et al. Living-related versus deceased donor pediatric liver transplantation: A multivariate analysis of technical and immunological complications in 235 recipients. Am J Transplant 2007: 7: 440-447.